Glucosamine affects intracellular signalling through inhibition of mitogen-activated protein kinase phosphorylation in human chondrocytes
Open Access
- 9 October 2007
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 9 (5) , R104
Abstract
The aim of this study was to determine the effects of glucosamine on matrix metalloprotease (MMP) production, on mitogen-activated protein kinase (MAPK) phosphorylation, and on activator protein (AP)-1 transcription factor activation in human chondrocytes. The human immortalized cell line lbpva55 and healthy human chondrocytes (obtained from healthy donors) were subjected to challenge with 10 ng/ml IL-1β after pretreatment with 2.5 or 10 mmol/l glucosamine. MMP mRNA expression levels were evaluated using quantitative real-time PCR, and MMP protein production levels were evaluated in the culture supernatant using ELISA. MAPK phosphorylation was evaluated using Western blotting. AP-1 transcription factor activation was evaluated by measuring AP-1 DNA-binding activity. After IL-1β stimulation, levels of MMP-1, MMP-3 and MMP-13 production were markedly increased. Treatment with 2.5 and 10 mmol/l glucosamine reduced expression of these metalloproteases. MMP expression is regulated by transcription factors such as the AP-1 complex, which is activated by phosphorylated MAPKs. IL-1β stimulated phosphorylation of c-jun amino-terminal kinase, p38 MAPK and extracellular signal-regulated kinase-1/2. Glucosamine inhibited c-jun amino-terminal kinase and p38 phosphorylation, and consequently c-jun binding activity. These findings demonstrate, for the first time, that glucosamine inhibits IL-1β-stimulated MMP production in human chondrocytes by affecting MAPK phosphorylation.Keywords
This publication has 41 references indexed in Scilit:
- Cell signaling, the essential role of O-GlcNAc!Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2006
- A Novel Role for GADD45β as a Mediator of MMP-13 Gene Expression during Chondrocyte Terminal DifferentiationJournal of Biological Chemistry, 2005
- Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E2 in articular cartilage explantsOsteoarthritis and Cartilage, 2005
- O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stressBiochimica et Biophysica Acta (BBA) - General Subjects, 2004
- Current status of glucosamine therapy in osteoarthritisArthritis & Rheumatism, 2003
- Glucosamine inhibits IL-1β-induced NFκB activation in human osteoarthritic chondrocytesOsteoarthritis and Cartilage, 2003
- Human articular chondrocytes immortalized by HPV-16 E6 and E7 genes:Osteoarthritis and Cartilage, 2002
- Glucosamine modulates IL‐1‐induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF‐κB pathwayFEBS Letters, 2001
- Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-jun N-terminal kinase, and nuclear factor κB: Differential regulation of collagenase 1 and collagenase 3Arthritis & Rheumatism, 2000
- Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patientsCurrent Medical Research and Opinion, 1982